MASTL: A novel therapeutic target for Cancer Malignancy
Open Access
- 21 July 2020
- journal article
- review article
- Published by Wiley in Cancer Medicine
- Vol. 9 (17) , 6322-6329
Abstract
Targeting mitotic kinases is an emerging anticancer approach with promising preclinical outcomes. Microtubule‐associated serine/threonine kinase like (MASTL), also known as Greatwall (Gwl), is an important mitotic kinase that regulates mitotic progression of normal or transformed cells by blocking the activity of tumor suppressor protein phosphatase 2A (PP2A). MASTL upregulation has now been detected in multiple cancer types and associated with aggressive clinicopathological features. Apart, an aberrant MASTL activity has been implicated in oncogenic transformation through the development of chromosomal instability and alteration of key oncogenic signaling pathways. In this regard, recent publications have revealed potential role of MASTL in the regulation of AKT/mTOR and Wnt/β‐catenin signaling pathways, which may be independent of its regulation of PP2A‐B55 (PP2A holoenzyme containing a B55‐family regulatory subunit). Taken together, MASTL kinase has emerged as a novel target for cancer therapeutics, and hence development of small molecule inhibitors of MASTL may significantly improve the clinical outcomes of cancer patients. In this article, we review the role of MASTL in cancer progression and the current gaps in this knowledge. We also discuss potential efficacy of MASTL expression for cancer diagnosis and therapy.Keywords
Funding Information
- National Cancer Institute Cancer Center (P30 CA036727, BX002761)
This publication has 78 references indexed in Scilit:
- Cyclins and Cell Cycle Control in Cancer and DiseaseGenes & Cancer, 2012
- The overlooked greatwall: a new perspective on mitotic controlOpen Biology, 2012
- Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balanceProceedings of the National Academy of Sciences, 2010
- Activation of cyclin B1–Cdk1 synchronizes events in the nucleus and the cytoplasm at mitosisJournal of Cell Biology, 2010
- Progressive Activation of CyclinB1-Cdk1 Coordinates Entry to MitosisDevelopmental Cell, 2010
- The M Phase Kinase Greatwall (Gwl) Promotes Inactivation of PP2A/B55δ, a Phosphatase Directed Against CDK PhosphositesMolecular Biology of the Cell, 2009
- Greatwall maintains mitosis through regulation of PP2AThe EMBO Journal, 2009
- PR55α, a Regulatory Subunit of PP2A, Specifically Regulates PP2A-mediated β-Catenin DephosphorylationJournal of Biological Chemistry, 2009
- Fine Tuning the Cell Cycle: Activation of the Cdk1 Inhibitory Phosphorylation Pathway during Mitotic ExitMolecular Biology of the Cell, 2009
- Cyclin B1–Cdk1 Activation Continues after Centrosome Separation to Control Mitotic ProgressionPLOS Biology, 2007